First, apologies for being so silent on a very bad day for Ebola; Canada today is undergoing a
Watergate-level political crisis that could see the government fall, or Prime Minister Justin Trudeau replaced.
EPIDEMIOLOGICAL SITUATION IN THE PROVINCES OF NORTH KIVU AND ITURI
Wednesday, February 27, 2019
The epidemiological situation of the Ebola Virus Disease dated February 26, 2019:
• Since the beginning of the epidemic, the cumulative number of cases is 879, of which 814 are confirmed and 65 are probable. In total, there were 553 deaths (488 confirmed and 65 probable).
• 229 suspected cases under investigation;
• 4 new confirmed cases, including 3 in Katwa and 1 in Butembo;
2 new confirmed deaths, 1 in Katwa and 1 in Butembo, all are community deaths.
/! \ Cleaning databases in progress: Revision of the database of people cured. We will start sharing the number of cures as soon as the revision is complete.

News of the response
Attack on Butembo Ebola Treatment Center
• On the evening of Wednesday, February 27, 2019, unidentified gunmen attacked the Butembo CTE co-managed by Médecins Sans Frontières and the Ministry of Health. This attack took place only three days after the arson attack of the Katwa CTE, the neighboring health zone.
• At the time of the attack, 38 suspected patients and 12 confirmed patients were treated at the CTE. Of the suspected patients, 32 fled. And among the confirmed cases, 8 were found in their single rooms. Research is underway to find the 4 confirmed fugitives. All the patients found, as well as the medical staff, are safe and unharmed. The patients were temporarily transferred to the Butembo Transit Center operationalized by Alima.
Workshop on the implementation of the 3rd Strategic Plan Response
• On Tuesday, February 26, 2019, the Minister of Health, Dr Oly Ilunga Kalenga, opened in Goma, the workshop on the implementation of the third strategic plan for response to the Ebola epidemic (SRP 3) in provinces of North Kivu and Ituri. This workshop brought together all the national and international actors of the response, including all the health authorities of the different health zones of the region.
• The purpose of the two-day workshop was to explain the PSR 3 to all local health authorities, senior staff of strategic coordination and sub-coordination as well as to gain ownership of the plan to ensure better Implementation.
• This new plan focuses on three important areas:
1. The anchoring of the response in the local health system: The leadership and the expertise of the response belong to the specialized teams while the optimization of the functioning of the health system is the responsibility of the actors of the local health system (Provincial Division of Health). Health, Health Zone and Health Area).
2. Establishment of an information management system: The information management mechanism has been strengthened to improve data collection and analysis at all levels.
3. The importance of accountability: An important addition in SRP 3 is the accountability framework for each stakeholder involved in the response, both local providers and international partners. This accountability framework clearly identifies the roles and responsibilities of each organization in the response to assess their performance on the ground.
Vaccination
• Since the beginning of vaccination on 8 August 2018, 84,094 persons have been vaccinated , including 21,504 in Katwa, 20,679 in Beni, 10,486 in Butembo, 6,109 in Mabalako, 2,839 in Kalunguta, 2,590 in Goma, 2,317 in Komanda, 2,084 in Oicha, 1,813 to Mandima, 1,357 to Karisimbi, 1,325 to Kyondo, 1,283 to Kayina, 1,094 to Bunia, 1,064 to Vuhovi, 920 to Masereka, 772 to Mutwanga, 769 to Lubero, 767 to Biena, 590 to Rutshuru, 583 to Musienene, 527 in Nyankunde, 496 in Mangurujipa, 426 in Rwampara (Ituri), 355 in Tchomia, 333 in Lolwa, 280 in Mambasa, 254 in Alimbongo, 207 in Kirotshe, 161 in Nyiragongo, 97 in Watsa (Haut-Uélé) and 13 in Kisangani.
• The only vaccine to be used in this outbreak is the rVSV-ZEBOV vaccine, manufactured by the pharmaceutical group Merck, following approval by the Ethics Committee in its decision of 19 May 2018.
Recent Comments